The Innovation Firm

USPTO Reexamination Trumps Federal Court Opinions of Patent Validity
August 21, 2013 - Hamilton Brook Smith Reynolds Alert
By: David E. Brook
A party accused of infringing a patent can fail to invalidate the patent in the courts but still win based on a decision of invalidity in a reexamination proceeding at the United...
More »
 
We are Expanding to Boston's Seaport District!
August 13, 2013
In early September 2013, Hamilton Brook Smith Reynolds will officially open an additional office in Boston's Seaport District.  The new office, which is located...
More »
 
LMG Life Sciences Highly Recommends Hamilton Brook Smith Reynolds
August 8, 2013 - LMG Life Sciences
The following is an excerpt from an article in LMG Life Sciences 2013. IP boutique Hamilton Brook Smith Reynolds has an impressive reputation in the marketplace.  &...
More »
 
IAM Magazine Recognizes Hamilton Brook Smith Reynolds as a Recommended Patent Law Firm
July 17, 2013 - IAM Patent 1000
The following is an excerpt from this article in IAM Patent 1000. “Thriving boutique” Hamilton Brook Smith Reynolds has become a firm favourite on the Massachusetts...
More »
 
The Impact of the AIA
The Impact of the AIA Tap into our wealth of resources on the AIA.  Replay our recent webcasts on the AIA.  Or read the many informative alerts on several AIA ...
More »
 
WEBCAST RECORDING: Trademark Basics - How to Select Good Trademarks and Effectively Protect Them
June 19, 2013
For many companies, their trademarks or brands are how the companies are held out to their customers and how they are perceived in the market place.  The trademark tells their...
More »
 
Fighting It Out in the Patent Office - Early Experiences and Observations about IPRs
June 19, 2013
On June 19, 2013, Susan Glovsky, Principal, co-presented the Boston Patent Law Association's Contested Matters Committee "Fighting It Out in the Patent Office - Early...
More »
 
Third-Party Clinical Trials Not Considered “Public Use”
June 18, 2013 - Hamilton Brook Smith Reynolds Alert
By: Kristen K. Salvaggio
Public use inquiry is focused on the knowledge obtained by the public during clinical trial of a drug, rather than on the extent of use of the drug. Confidentiality controls implemented...
More »
 

« previous | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | next »

USPTO Reexamination Trumps Federal Court Opinions of Patent Validity
August 21, 2013 - Hamilton Brook Smith Reynolds Alert
By: David E. Brook
A party accused of infringing a patent can fail to invalidate the patent in the courts but still win based on a decision of invalidity in a reexamination proceeding at the United...
More »
 
We are Expanding to Boston's Seaport District!
August 13, 2013
In early September 2013, Hamilton Brook Smith Reynolds will officially open an additional office in Boston's Seaport District.  The new office, which is located...
More »
 
LMG Life Sciences Highly Recommends Hamilton Brook Smith Reynolds
August 8, 2013 - LMG Life Sciences
The following is an excerpt from an article in LMG Life Sciences 2013. IP boutique Hamilton Brook Smith Reynolds has an impressive reputation in the marketplace.  &...
More »
 
IAM Magazine Recognizes Hamilton Brook Smith Reynolds as a Recommended Patent Law Firm
July 17, 2013 - IAM Patent 1000
The following is an excerpt from this article in IAM Patent 1000. “Thriving boutique” Hamilton Brook Smith Reynolds has become a firm favourite on the Massachusetts...
More »
 
The Impact of the AIA
The Impact of the AIA Tap into our wealth of resources on the AIA.  Replay our recent webcasts on the AIA.  Or read the many informative alerts on several AIA ...
More »
 
WEBCAST RECORDING: Trademark Basics - How to Select Good Trademarks and Effectively Protect Them
June 19, 2013
For many companies, their trademarks or brands are how the companies are held out to their customers and how they are perceived in the market place.  The trademark tells their...
More »
 
Fighting It Out in the Patent Office - Early Experiences and Observations about IPRs
June 19, 2013
On June 19, 2013, Susan Glovsky, Principal, co-presented the Boston Patent Law Association's Contested Matters Committee "Fighting It Out in the Patent Office - Early...
More »
 
Third-Party Clinical Trials Not Considered “Public Use”
June 18, 2013 - Hamilton Brook Smith Reynolds Alert
By: Kristen K. Salvaggio
Public use inquiry is focused on the knowledge obtained by the public during clinical trial of a drug, rather than on the extent of use of the drug. Confidentiality controls implemented...
More »
 

« previous | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | next »

Back to the Top